drugset / Trial / NCT01722916

Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

NCT01722916

Phase 0 Completed 5 enrolled Northwestern University
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

Timeline

Start
2012-10
Primary completion
2022-02-22
Completion
2022-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject rHuPH20 Protein / enzyme biologic 1.5 iu
Subject rHuPH20 Protein / enzyme biologic 3 iu
Subject rHuPH20 Protein / enzyme biologic 9 iu

Indications

No indication recorded.